Drug Shortage Report for CAVERJECT STERILE POWDER
Report ID | 98076 |
Drug Identification Number | 02215756 |
Brand name | CAVERJECT STERILE POWDER |
Common or Proper name | Caverject |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ALPROSTADIL |
Strength(s) | 23.2MCG |
Dosage form(s) | KIT LIQUID POWDER FOR SOLUTION |
Route of administration | INTRACAVERNOSAL |
Packaging size | 5 x 20MCG VIALS |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-29 |
Estimated end date | 2020-10-30 |
Actual end date | 2020-10-26 |
Shortage status | Resolved |
Updated date | 2020-10-27 |
Company comments | This shortage also includes : DIN 02215187 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-06 | English | Compare |
v2 | 2019-11-06 | French | Compare |
v3 | 2020-02-10 | English | Compare |
v4 | 2020-02-10 | English | Compare |
v5 | 2020-02-10 | French | Compare |
v6 | 2020-08-03 | English | Compare |
v7 | 2020-08-03 | French | Compare |
v8 | 2020-10-15 | English | Compare |
v9 | 2020-10-15 | French | Compare |
v10 | 2020-10-26 | English | Compare |
v11 | 2020-10-26 | French | Compare |
v12 | 2020-10-27 | English | Compare |
Showing 1 to 12 of 12